These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 30803240)
1. Targeting CAIX with [ Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240 [TBL] [Abstract][Full Text] [Related]
2. [64Cu]XYIMSR-06: A dual-motif CAIX ligand for PET imaging of clear cell renal cell carcinoma. Minn I; Koo SM; Lee HS; Brummet M; Rowe SP; Gorin MA; Sysa-Shah P; Lewis WD; Ahn HH; Wang Y; Banerjee SR; Mease RC; Nimmagadda S; Allaf ME; Pomper MG; Yang X Oncotarget; 2016 Aug; 7(35):56471-56479. PubMed ID: 27437764 [TBL] [Abstract][Full Text] [Related]
3. A CAIX Dual-Targeting Small-Molecule Probe for Noninvasive Imaging of ccRCC. He C; Liu F; Tao J; Wang Z; Liu J; Liu S; Xu X; Li L; Wang F; Yang X; Zhu H; Yang Z Mol Pharm; 2024 Jul; 21(7):3383-3394. PubMed ID: 38831541 [TBL] [Abstract][Full Text] [Related]
4. Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor. Yang X; Minn I; Rowe SP; Banerjee SR; Gorin MA; Brummet M; Lee HS; Koo SM; Sysa-Shah P; Mease RC; Nimmagadda S; Allaf ME; Pomper MG Oncotarget; 2015 Oct; 6(32):33733-42. PubMed ID: 26418876 [TBL] [Abstract][Full Text] [Related]
5. PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with (68)Ga-Labeled Benzenesulfonamides. Lau J; Zhang Z; Jenni S; Kuo HT; Liu Z; Vullo D; Supuran CT; Lin KS; Bénard F Mol Pharm; 2016 Mar; 13(3):1137-46. PubMed ID: 26866675 [TBL] [Abstract][Full Text] [Related]
6. Development of the Iikuni S; Tanimura K; Watanabe H; Shimizu Y; Saji H; Ono M Mol Pharm; 2019 Apr; 16(4):1489-1497. PubMed ID: 30892905 [TBL] [Abstract][Full Text] [Related]
7. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT. Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858 [TBL] [Abstract][Full Text] [Related]
8. PET imaging and pharmacological therapy targeting carbonic anhydrase-IX high-expressing tumors using US2 platform based on bivalent ureidosulfonamide. Iikuni S; Watanabe H; Shimizu Y; Nakamoto Y; Ono M PLoS One; 2020; 15(12):e0243327. PubMed ID: 33296398 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of 64Cu-labeled acridinium cation: a PET radiotracer targeting tumor mitochondria. Zhou Y; Kim YS; Shi J; Jacobson O; Chen X; Liu S Bioconjug Chem; 2011 Apr; 22(4):700-8. PubMed ID: 21413736 [TBL] [Abstract][Full Text] [Related]
10. ImmunoPET Imaging of CD146 in Murine Models of Intrapulmonary Metastasis of Non-Small Cell Lung Cancer. England CG; Jiang D; Hernandez R; Sun H; Valdovinos HF; Ehlerding EB; Engle JW; Yang Y; Huang P; Cai W Mol Pharm; 2017 Oct; 14(10):3239-3247. PubMed ID: 28825843 [TBL] [Abstract][Full Text] [Related]
11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
12. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors. Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724 [TBL] [Abstract][Full Text] [Related]
13. Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers. Marks IS; Gardeen SS; Kurdziel SJ; Nicolaou ST; Woods JE; Kularatne SA; Low PS Mol Pharm; 2018 Jun; 15(6):2289-2296. PubMed ID: 29715036 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature. Chen K; Sun X; Niu G; Ma Y; Yap LP; Hui X; Wu K; Fan D; Conti PS; Chen X Mol Imaging Biol; 2012 Feb; 14(1):96-105. PubMed ID: 21360213 [TBL] [Abstract][Full Text] [Related]
15. Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma. Cheal SM; Punzalan B; Doran MG; Evans MJ; Osborne JR; Lewis JS; Zanzonico P; Larson SM Eur J Nucl Med Mol Imaging; 2014 May; 41(5):985-94. PubMed ID: 24604591 [TBL] [Abstract][Full Text] [Related]
17. ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in mice. Stillebroer AB; Franssen GM; Mulders PF; Oyen WJ; van Dongen GA; Laverman P; Oosterwijk E; Boerman OC Cancer Biother Radiopharm; 2013 Sep; 28(7):510-5. PubMed ID: 23697926 [TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the monoclonal antibody Čepa A; Ráliš J; Král V; Paurová M; Kučka J; Humajová J; Lázníček M; Lebeda O Appl Radiat Isot; 2018 Mar; 133():9-13. PubMed ID: 29272822 [TBL] [Abstract][Full Text] [Related]
19. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes. Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034 [TBL] [Abstract][Full Text] [Related]